These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 13673276)

  • 1. Biologic studies on the development of DON resistance in a mast-cell neoplasm of the mouse.
    POTTER M
    J Natl Cancer Inst; 1959 Jul; 23(1):163-81. PubMed ID: 13673276
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies of a plasma-cell neoplasm of the mouse. I. Characterization of neoplasm 70429, including its sensitivity to various antimetabolites with the rapid development of resistance to azaserine, DON, and N-methylformamide.
    POTTER M; LAW LW
    J Natl Cancer Inst; 1957 Mar; 18(3):413-41. PubMed ID: 13406561
    [No Abstract]   [Full Text] [Related]  

  • 3. Biologic studies on the development of DON resistance in a mast-cell neoplasm of the mouse.
    POTTER M
    J Natl Cancer Inst; 1959 Jul; 23():163-81. PubMed ID: 14434476
    [No Abstract]   [Full Text] [Related]  

  • 4. A transplantable mast-cell neoplasm in the mouse.
    DUNN TB; POTTER M
    J Natl Cancer Inst; 1957 Apr; 18(4):587-601. PubMed ID: 13416911
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diazo derivates of amino acids and peptides as possible antineoplastic chemotherapeutic agents. III. Activity on Galliera sarcoma of 2 N-diazoacetyl derivatives of glycine in comparison with azaserine and DON].
    BALDINI L; BRAMBILLA G; MATTIOLI F
    Boll Soc Ital Biol Sper; 1960 Nov; 36():1188-92. PubMed ID: 13686269
    [No Abstract]   [Full Text] [Related]  

  • 6. Deoxynivalenol (DON) is toxic to human colonic, lung and monocytic cell lines, but does not increase the IgE response in a mouse model for allergy.
    Instanes C; Hetland G
    Toxicology; 2004 Nov; 204(1):13-21. PubMed ID: 15369845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling therapy resistance in genetically engineered mouse cancer models.
    Rottenberg S; Jonkers J
    Drug Resist Updat; 2008; 11(1-2):51-60. PubMed ID: 18165147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RasGRP4 in mast cell signalling and disease susceptibility.
    Stevens RL; Morokawa N; Wang J; Krilis SA
    Novartis Found Symp; 2005; 271():54-68; discussion 68-77, 95-9. PubMed ID: 16605128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental research on the behavior of vestibular function after the administration of certain drugs. II. Acetyl-DL-leucine].
    CHINELLATO F
    Boll Soc Ital Biol Sper; 1960 Oct; 36():1128-30. PubMed ID: 13693109
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-tumor angiogenesis effect of aminopeptidase inhibitor bestatin against B16-BL6 melanoma cells orthotopically implanted into syngeneic mice.
    Aozuka Y; Koizumi K; Saitoh Y; Ueda Y; Sakurai H; Saiki I
    Cancer Lett; 2004 Dec; 216(1):35-42. PubMed ID: 15500947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [STUDIES ON THE ULTRASTRUCTURE OF A VARIANT OF FURTH'S MOUSE MASTOCYTOMA].
    SELLYEI M; DAVID H
    Z Mikrosk Anat Forsch; 1963; 70():103-17. PubMed ID: 14070592
    [No Abstract]   [Full Text] [Related]  

  • 12. Fluvastatin inhibits mast cell degranulation without changing the cytoplasmic Ca2+ level.
    Fujimoto M; Oka T; Murata T; Hori M; Ozaki H
    Eur J Pharmacol; 2009 Jan; 602(2-3):432-8. PubMed ID: 19059394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Action of acetylleucine on experimental vertigo in mice].
    LEAU O; DUCROT R
    C R Seances Soc Biol Fil; 1957; 151(7):1365-7. PubMed ID: 13523909
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular mechanisms of mast cell development.
    Kitamura Y; Oboki K; Ito A
    Immunol Allergy Clin North Am; 2006 Aug; 26(3):387-405; v. PubMed ID: 16931285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ability to detoxify the mycotoxin deoxynivalenol colocalizes with a major quantitative trait locus for Fusarium head blight resistance in wheat.
    Lemmens M; Scholz U; Berthiller F; Dall'Asta C; Koutnik A; Schuhmacher R; Adam G; Buerstmayr H; Mesterházy A; Krska R; Ruckenbauer P
    Mol Plant Microbe Interact; 2005 Dec; 18(12):1318-24. PubMed ID: 16478051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DEGA/AMIGO-2, a leucine-rich repeat family member, differentially expressed in human gastric adenocarcinoma: effects on ploidy, chromosomal stability, cell adhesion/migration and tumorigenicity.
    Rabenau KE; O'Toole JM; Bassi R; Kotanides H; Witte L; Ludwig DL; Pereira DS
    Oncogene; 2004 Jun; 23(29):5056-67. PubMed ID: 15107827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mouse mast cell-restricted tetramer-forming tryptases mouse mast cell protease 6 and mouse mast cell protease 7 are critical mediators in inflammatory arthritis.
    McNeil HP; Shin K; Campbell IK; Wicks IP; Adachi R; Lee DM; Stevens RL
    Arthritis Rheum; 2008 Aug; 58(8):2338-46. PubMed ID: 18668540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human mast cells release oncostatin M on contact with activated T cells: possible biologic relevance.
    Salamon P; Shoham NG; Puxeddu I; Paitan Y; Levi-Schaffer F; Mekori YA
    J Allergy Clin Immunol; 2008 Feb; 121(2):448-455.e5. PubMed ID: 18028996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemosensitization of cancer in vitro and in vivo by nitric oxide signaling.
    Frederiksen LJ; Sullivan R; Maxwell LR; Macdonald-Goodfellow SK; Adams MA; Bennett BM; Siemens DR; Graham CH
    Clin Cancer Res; 2007 Apr; 13(7):2199-206. PubMed ID: 17404104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The distribution of mast cells in benign and malignant prostate lesions and its biologic significance].
    Deng WB; Li P; Li GX; Zhao Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):623-5. PubMed ID: 15460402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.